Simplex Trading
HBIO icon

Simplex Trading’s Harvard Bioscience HBIO Stock Holding History

Simplex Trading’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-530
Closed -$3.54K – 9495
2025
Q4 		$3.54K Sell
530
-50
-9% -$297 ﹤0.01% 7607
2025
Q3 		$2K Sell
580
-20
-3% -$95 ﹤0.01% 8648
2025
Q2 		$2K Buy
+600
New +$2.51K ﹤0.01% 8133
2023
Q4 		– Sell
-50
Closed -$2K – 9204
2023
Q3 		$2K Sell
50
-20
-29% -$923 ﹤0.01% 8102
2023
Q2 		$3K Buy
+70
New +$3.84K ﹤0.01% 8223
2022
Q3 		– Sell
-30
Closed -$1K – 10294
2022
Q2 		$1K Sell
30
-470
-94% -$21.2K ﹤0.01% 9586
2022
Q1 		$31K Buy
500
+210
+72% +$12.4K ﹤0.01% 7725
2021
Q4 		$20K Sell
290
-140
-33% -$9.95K ﹤0.01% 8355
2021
Q3 		$35K Hold
430
– – ﹤0.01% 7950
2021
Q2 		$35K Buy
430
+428
+21,400% +$30.3K ﹤0.01% 8081
2021
Q1 		$10K Buy
2
+1
+100% +$49 ﹤0.01% 7883
2020
Q4 		$4K Buy
+1
New +$37 ﹤0.01% 7786
2019
Q4 		– Sell
-6
Closed -$18K – 7539
2019
Q3 		$18K Buy
6
+4
+200% +$99 ﹤0.01% 5887
2019
Q2 		$3K Buy
2
+1
+100% +$29 ﹤0.01% 6633
2019
Q1 		$2K Buy
+1
New +$36 ﹤0.01% 6781
2017
Q4 		– Sell
-1
Closed -$1K – 6239
2017
Q3 		$1K Buy
+1
New +$30 ﹤0.01% 5431
2016
Q1 		– Hold
0
– -$1K – 5844
2015
Q4 		– Hold
0
– – – 4873

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $100M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's HBIO Position: Q1 2026 in Review

Simplex Trading sold out of Harvard Bioscience (HBIO) in Q1 2026, closing a stake of 1,379 shares — an estimated $9.22K sold.

Simplex Trading first reported a position in HBIO in Q3 2017 and held it in 16 quarters. The position peaked at $29K in Q3 2018. 36 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.

  • Simplex Trading reported no remaining Harvard Bioscience position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 1,379 Harvard Bioscience shares in Q1 2026, an estimated $9.22K.
  • Simplex Trading first reported a position in Harvard Bioscience in Q3 2017 and held it in 16 quarters.
  • Simplex Trading's Harvard Bioscience position peaked at $29K in Q3 2018.
  • 36 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.